- $5.97m
- $57.40m
- $176.72m
- 40
- 94
- 28
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 33 | 54.9 | 185 | 222 | 177 |
Cost of Revenue | |||||
Gross Profit | 8.94 | 9.87 | 46.5 | 64.9 | 63.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 41.1 | 67.6 | 192 | 218 | 203 |
Operating Profit | -8.06 | -12.7 | -7.1 | 3.9 | -26.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.4 | -17 | -10.5 | -3.69 | -37.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.4 | -16.2 | -13.8 | -3.74 | -39.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -9.4 | -16.2 | -13.8 | -3.74 | -39.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.4 | -16.5 | -14.7 | -5.01 | -40.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -7.04 | -3.06 | -1.6 | -0.644 | -2.54 |